WallStreetZenWallStreetZen

NASDAQ: BOLT
Bolt Biotherapeutics Inc Stock Ownership - Who owns Bolt Biotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bolt Biotherapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah NemecSenior VP Finance and PAO2024-12-162,500$0.50
$1.24kBuy
William P. QuinnPresident CEO and CFO2024-12-162,500$0.50
$1.24kBuy

1 of 1

BOLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BOLT insiders and whales buy or sell their stock.

BOLT Shareholders

What type of owners hold Bolt Biotherapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Capital VIII LLC307.04%5,885,846$35.90MInsider
Tang Capital Management LLC198.89%3,812,773$23.26MInstitution
Holdings A. Novo193.22%3,703,991$22.59MInsider
Vivo Capital LLC183.69%3,521,291$21.48MInstitution
Edgar Engleman171.80%3,293,286$20.09MInsider
James Healy143.69%2,754,437$16.80MInsider
Sofinnova Venture Partners X LP143.69%2,754,437$16.80MInsider
Sofinnova Investments Inc143.69%2,754,437$16.80MInstitution
Pivotal Bioventure Partners Investment Advisor LLC98.67%1,891,467$11.54MInstitution
Mahendra Shah75.55%1,448,286$8.83MInsider

1 of 3

BOLT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BOLT47.85%52.15%Net Buying
LIPO0.06%39.77%
BCTX0.57%99.43%
ATHA44.99%31.83%Net Selling
BCDA0.13%99.87%Net BuyingNet Buying
View Top Biotech Stocks

Bolt Biotherapeutics Stock Ownership FAQ

Who owns Bolt Biotherapeutics?

Bolt Biotherapeutics (NASDAQ: BOLT) is owned by 955.98% institutional shareholders, 1,041.74% Bolt Biotherapeutics insiders, and 0.00% retail investors. Vivo Capital VIII LLC is the largest individual Bolt Biotherapeutics shareholder, owning 5.89M shares representing 307.04% of the company. Vivo Capital VIII LLC's Bolt Biotherapeutics shares are currently valued at $35.90M.

If you're new to stock investing, here's how to buy Bolt Biotherapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.